ALPEK (ALPEKA) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
27 Dec, 2025Executive summary
Navigated a challenging market with global overcapacity, lower freight costs, and increased import competition, especially impacting the polyester segment.
1Q25 volume was 1,119 ktons, flat sequentially and down 7% year-over-year, reflecting softer demand and persistent global overcapacity, especially in Polyester.
Comparable EBITDA reached $126 million, down 25% QoQ and 18% YoY, in line with expectations amid market volatility.
Controladora Alpek was listed on the Mexican Stock Exchange in April 2025, with a planned merger with ALPEKA by end of 2025 to enhance liquidity and shareholder value.
Four strategic pillars: solidifying core business, boosting value-added products, capitalizing on emerging trends, and maintaining financial flexibility.
Financial highlights
Revenues were $1.72 billion, down 1% sequentially and 10% YoY, mainly due to lower volumes and softer pricing.
Quarterly oil/total volume was 1.12 million tons, down 7% year-over-year and flat sequentially.
Reported EBITDA was $131 million, including a $15 million inventory adjustment and $10 million in shutdown/reorganization costs.
Comparable EBITDA was $126 million, down 18% year-over-year and 25% sequentially.
Operating free cash flow was $8 million for the quarter, improving from prior quarters.
Outlook and guidance
2025 guidance is under review due to evolving tariff dynamics and demand shifts; no update provided yet.
Focus remains on cost structure improvement, asset productivity, and financial flexibility.
Demand expected to gradually recover in coming quarters; working capital normalization anticipated in the second half.
Guidance for Chinese PET margins remains around $160/ton, with recent improvement seen in April.
Reducing leverage to 2.5x remains a priority, with working capital release expected by year-end, below $100 million.
Latest events from ALPEK
- 2026 guidance targets $450–$500M EBITDA, with deleveraging and cost controls prioritized.ALPEKA
Q4 202511 Feb 2026 - Stable volumes, $75M cost savings, and lower leverage support 2024 guidance.ALPEKA
Q2 20242 Feb 2026 - Q3 delivered record EBITDA, raised guidance, and progress on spin-off and cost savings.ALPEKA
Q3 202418 Jan 2026 - 2024 EBITDA beat guidance, cost savings hit $75M, and leverage improved to 2.9x.ALPEKA
Q4 202416 Dec 2025 - Lower earnings and revised guidance amid global oversupply, tariffs, and operational disruptions.ALPEKA
Q2 202516 Nov 2025 - EBITDA and cash flow rose sequentially, but oversupply and lower prices pressured guidance.ALPEKA
Q3 202523 Oct 2025